Wilbanks Smith & Thomas Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
+$13.5M |
| 2 |
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
|
+$13.4M |
| 3 |
VQT
iPath S&P VEQTOR ETN
VQT
|
+$9.6M |
| 4 |
WisdomTree International SmallCap Dividend Fund
DLS
|
+$7.85M |
| 5 |
Invesco S&P 500 Equal Weight Technology ETF
RSPT
|
+$2.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Top 50 ETF
XLG
|
+$10.7M |
| 2 |
Invesco International Dividend Achievers ETF
PID
|
+$7.93M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$3.21M |
| 4 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$2.91M |
| 5 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$1.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 8.64% |
| 2 | Consumer Staples | 4.63% |
| 3 | Energy | 4.61% |
| 4 | Healthcare | 4.06% |
| 5 | Technology | 3.86% |
Similar funds
Wilbanks Smith & Thomas Asset Management's Q4 2013 Portfolio in Review
As of Q4 2013, Wilbanks Smith & Thomas Asset Management held 319 positions worth $841M, up 12% from $749M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Wilbanks Smith & Thomas Asset Management deployed $26.2M of net new capital in Q4 2013, opening 38 new positions and adding to 87 existing holdings. Its largest new stake was iPath S&P VEQTOR ETN: 67,354 shares worth $9.84M.
By sector, the portfolio is most concentrated in Industrials at 8.6% of assets, up from 8.5% a quarter earlier, followed by Consumer Staples and Energy.
On the sell side, the largest reduction was Invesco S&P 500 Top 50 ETF, an estimated $10.7M trimmed.
- Wilbanks Smith & Thomas Asset Management's largest Q4 2013 buy was iPath S&P VEQTOR ETN: 67,354 shares worth $9.84M.
- Wilbanks Smith & Thomas Asset Management added most to iShares MSCI EAFE Value ETF in Q4 2013, an estimated $13.5M increase.
- Wilbanks Smith & Thomas Asset Management's biggest Q4 2013 reduction was Invesco S&P 500 Top 50 ETF, cutting an estimated $10.7M.
- Wilbanks Smith & Thomas Asset Management fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $1.09M.
- Wilbanks Smith & Thomas Asset Management's ten largest holdings make up 42% of its $841M portfolio in Q4 2013.
- Wilbanks Smith & Thomas Asset Management opened 38 new positions and closed 28 in Q4 2013.
- Wilbanks Smith & Thomas Asset Management's portfolio value rose 12% quarter-over-quarter to $841M.
Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2013, filed 28 Jan 2014.